This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: Berkshire Hathaway, AbbVie, Booking, HCA and Kimberly-Clark
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, AbbVie, Booking, HCA and Kimberly-Clark
Top Research Reports for Berkshire Hathaway, AbbVie & Booking Holdings
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), AbbVie (ABBV) and Booking Holdings (BKNG).
Consumer Products Industry Outlook: Soft Margin Blurs Prospects
by Zacks Equity Research
Demand for most products in this industry remains more or less stable. Players are focused on getting more out of their operations and coming up with unique revenue-boosting initiatives.
Stocks Erase 2018 Gains: Here's What Stayed Green Today
by Ryan McQueeney
Stocks tumbled on Wednesday, erasing the year-to-date gains of at least two major indexes and proving that a number of market-wide and industry-specific headwinds are still weighing heavily on the minds of investors as a brutal October on Wall Street trudges along.
Company News For Oct 23, 2018
by Zacks Equity Research
Companies in the news are: HAS, PII, ARII and KMB
China's Stock Market Rally & Earnings Previews for CAT, MCD, and LMT
by Ryan McQueeney
Ryan McQueeney discusses a rally in the Chinese stock market and recent developments in the Italian budget crisis. He also recaps earnings results from Halliburton and Kimberly-Clark. Later, the host previews key reports due tomorrow morning, including those of Caterpillar, McDonald's, and Lockheed Martin.
Q3 Earnings Continue
by Zacks Equity Research
Q3 Earnings Continue
Chinese Markets Bounce Back, U.S. Pre-Market Green
by Mark Vickery
After weeks of crushing selloffs in the world's second-largest economy, we see 5% gains in the Shenzhen index.
Kimberly-Clark (KMB) Q3 Earnings Top Estimates, Sales Dip Y/Y
by Zacks Equity Research
Kimberly-Clark's Q3 sales were negatively impacted by adverse currency rates and volumes. However, the company's strategic cost savings efforts continued to yield.
Kimberly-Clark (KMB) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Kimberly-Clark (KMB) delivered earnings and revenue surprises of 4.27% and 1.30%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Kimberly-Clark (KMB) Q3 Earnings: High Input Costs a Worry
by Zacks Equity Research
Kimberly-Clark's (KMB) Q3 results to be hurt by rising input costs and lower net selling prices. Nevertheless, the company's savings initiatives are expected to offer respite.
Kimberly-Clark (KMB) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
Kimberly-Clark (KMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Kimberly-Clark's (KMB) Savings Efforts Pare Cost Woes?
by Zacks Equity Research
Kimberly-Clark (KMB) focuses on enhancing savings through the FORCE and Global Restructuring Programs. However, high input costs are a worry.
Kimberly-Clark (KMB) Up 9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Kimberly-Clark (KMB) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
Kimberly-Clark (KMB) Banks on FORCE Program to Offset Costs
by Zacks Equity Research
Kimberly-Clark's robust cost-saving efforts and regular innovation help the company outperform the industry over the past three months.
Kimberly-Clark (KMB) Surges: Stock Moves 5.4% Higher
by Zacks Equity Research
Kimberly-Clark (KMB) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.
Kimberly-Clark (KMB) Tops Q2 Earnings, Cuts View on Cost Woes
by Zacks Equity Research
Kimberly-Clark's (KMB) Q2 earnings and sales grow year over year. However, 2018 results are likely to be hurt by considerable commodity inflation.
Kimberly-Clark (KMB) Beats Q2 Earnings Estimates
by Zacks Equity Research
Kimberly-Clark (KMB) delivered earnings and revenue surprises of 1.27% and -0.03%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Kimberly-Clark (KMB) Stock Down Despite Q2 Earnings Beat
by Zacks Equity Research
Kimberly-Clark's (KMB) Q2 earnings came ahead of the Zacks Consensus Estimate and also improved year-on-year.
Can Savings Keep Kimberly-Clark (KMB) Afloat in Q2 Earnings?
by Zacks Equity Research
Kimberly-Clark (KMB) struggles with higher commodity costs and lower selling prices. However, robust cost reduction efforts are likely to aid performance in Q2.
Will Restructuring Plans Revive Kimberly-Clark's Stock?
by Zacks Equity Research
Kimberly-Clark's (KMB) strong focus on its Focus on Reducing Costs Everywhere program as along with its 2018 Global Restructuring plan should help it offset input cost inflation.
The Zacks Analyst Blog Highlights: CSX, Eni, Kimberly-Clark, Caterpillar and Check Point Software
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CSX, Eni, Kimberly-Clark, Caterpillar and Check Point Software
Top Research Reports for CSX Corporation, Eni & Kimberly-Clark
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including CSX Corporation (CSX), Eni (E) and Kimberly-Clark (KMB).
The Zacks Analyst Blog Highlights: Merck, Occidental Petroleum, Capital One Financial, Kimberly-Clark and Allstate
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Merck, Occidental Petroleum, Capital One Financial, Kimberly-Clark and Allstate
Top Analyst Reports for Merck, Occidental Petroleum & Capital One Financial
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Occidental Petroleum (OXY) and Capital One Financial (COF).